(R) -BDP9066
(R) -BDP9066 is an isomer of BDP9066 and has lower activity compared to BDP9066. BDP9066 is a potent inhibitor of myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK) . (R) -BDP9066 is derived from patent WO2019034890A1 (E118) [1].
Product Specifications
CAS Number
2284549-25-1
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Cdc42-binding kinase
Type
Reference compound
Related Pathways
Cytoskeleton
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/r-bdp9066.html
Purity
98.49
Solubility
DMSO : 20 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
N(CCC1)(C2=C3C(NC=C3C4=NC=NC=C4)=NC=C2)C[C@]51CCCCN5
Molecular Formula
C20H24N6
Molecular Weight
348.45
Precautions
H302, H315, H319, H335
References & Citations
[1]Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer. Patent WO2019034890A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mouse Parathyroid Hormone Related Protein,PTHrP Elisa Kit
Lentiviral human LONP1 shRNA (UAS) - Lentiviral human LONP1 shRNA (UAS) (25)
Recombinant Oltmannsiellopsis viridis Cytochrome b559 subunit alpha (psbE), partial
Ppm1b sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)